The Food and Drugs Authority (FDA) has cautioned the public to be vigilant when buying palm oil due to concerns raised about adulteration of the product.
Roderick Daddey-Adjei, the Deputy Chief Executive Officer of the FDA, explained that despite the Authority’s strict enforcement actions, some traders are still using the banned ‘Sudan Four dye’ to adulterate palm oil products on the market, a situation that poses a serious public health risk to consumers, as reported by citinewsroom.com.
He noted that while some progress has been made in reducing the prevalence of adulterated palm oil, even a small percentage of contamination is unacceptable.
“But we are still not happy about that small percentage that is there, which means that people who perpetrated the activity are still lurking in the dark. And we also want to let those who think that they can come back and keep on doing this, that their days are numbered. Because already with this one that we even did, we did some arrests, we have handed them over to the police,” he stated.
The caution from the FDA forms part of continued efforts to eliminate hazardous substances, specifically the notorious ‘Sudan Four’ dye from the market to ensure the safety of consumers.
